Recall Register

Drug recall: Prednisone Tablet USP, 20 mg tablets, packaged in blisters of ten (10) tablets per blister card, ten blister cards per…

Class III FDA enforcement event 65467. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Missing Label; missing label on blister card

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Boehringer Ingelheim Roxane Inc started this drug recall on 14 Jun 2013. The firm address in the FDA record is in Columbus, OH. FDA put the recall in Class III. FDA event 65467 has 1 product record. The first FDA enforcement report date is 21 Aug 2013. The record gives the status Terminated, with the termination date 23 Jun 2014.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

Boehringer Ingelheim Roxane Inc, Columbus, OH.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 65467: product records
Recall numberProductQuantityClassStatusReport date
D-882-2013Prednisone Tablet USP, 20 mg tablets, packaged in blisters of ten (10) tablets per blister card, ten blister cards per carton, Roxanne, Columbus, OH --- NDC 0054-0018-2014,619 cartonsClass IIITerminated21 Aug 2013

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2013
370
Share of these events in Class III
26%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
13

Other events of the firm

Other FDA enforcement events of Boehringer Ingelheim Roxane Inc
InitiatedProduct (first record)TypeClassRecords
25 Sep 2015FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane LaboratoriesDrugClass III2
24 Jul 2015COMBIVENT RESPIMAT (ipratropium bromide and albuterol) Inhalation Spray, 20 mcg/100 mcg per actuation*, 4 Grams, 120 MetDrugClass II1
2 Apr 2015Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, DrugClass II1
28 Jul 2014OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane LaboratorieDrugClass III1
1 May 2014Calcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-3120-DrugClass II1
4 Apr 2014Azathioprine Tablets USP, 50 mg, 100 count bottle, Rx only, Roxanne Laboratories, Inc., Columbus, Ohio, 43216, NDC 0054-DrugClass III2
27 Mar 2014Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With HandiHaler OnlyDrugClass III1
30 Aug 2013SPIRIVA HandiHaler (Tiotropium Bromide Inhalation Powder) Capsules 18 mcg per dose, Rx only, a) 10 count blister (NDC 05DrugClass III1
3 Apr 2013Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. ColuDrugClass II1
18 Mar 2013Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters packaged in a carton (NDC 0054DrugClass III1

Boehringer Ingelheim Roxane Inc: all 13 events

Official channels

Cite this page

Recall Register. FDA enforcement event 65467. https://recallregister.com/fda/iii/65467/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 65467?
The FDA record gives this quantity: 14,619 cartons
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2013 have the same class?
26% of the 370 drug events that started in 2013 are in Class III.